A research team at The University of Osaka has found a novel pathway for depositing CENP-A into vertebrate centromeres, which ...
In June 2025, Pluri Biotech Ltd., a wholly owned subsidiary of the Company, and a provider of Contract Development and Manufacturing (“CDMO”) services under its PluriCDMO™ business line, entered into ...
Pluri, Inc. ("Pluri", the "Company", "we" or "us") (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions ...
Petal size is a defining trait of ornamental flowers, directly shaping visual appeal and commercial value. A new study ...
Researchers often use a nematode worm called Caenorhabditis elegans (C. elegans) to study human genetics .. | Cell And ...
US FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001 to treat retinitis pigmentosa: Berlin, Germany Friday, January 23, 2026, 09 ...
By studying genetic data from nearly 140,000 IVF embryos, scientists have with unprecedented detail revealed why fewer than ...
MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.
When Dhaval Lakshmi, a satellite-tagged female Olive Ridley turtle, was released off the Dahanu coast in late November, she ...
News-Medical.Net on MSN
New partnership aims to expand global access to sickle cell gene therapy
Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results